House FDA funding bill advances, but not without some scolding
This article was originally published in Scrip
The House Appropriations Committee on 29 May voted 31-18 in favor of a legislative package that would fund the FDA for fiscal year 2015 at a slightly higher amount than the current year, although the measure came with some stern admonishing and explicit orders from lawmakers on how they think the agency should be run.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.